Arca
Skip to content
Tools
Tools

Anaplastic large-cell lymphoma

Drug research and approvals for anaplastic large-cell lymphoma: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 24 studies of anaplastic large-cell lymphoma are recruiting on ClinicalTrials.gov, and Health Canada has authorized 1 drug trials for it since 2013.

  • Recruiting worldwide: 24
  • Trials authorized in Canada: 1
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 24 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

Phase 3 2

Phase 2 12 of 33

Phase 1 or earlier 8

How its trials ended

207 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 70 whose ending is known, 44% met their primary endpoint, 4% missed it and 51% stopped early.

  • Completed, result not reported8642%
  • Ongoing3818%
  • Met its primary endpoint3115%
  • Stopped: other or unclear2311%
  • Status unknown136%
  • Stopped: enrollment or feasibility52%
  • Missed its primary endpoint31%
  • Stopped: lack of efficacy31%
  • Stopped: sponsor or business decision31%
  • Stopped: funding21%

Trials authorized in Canada

Newest first; search them all in Canada trials
AuthorizedTrialSponsorStatus
Jul 19, 2013A phase I, open-label, dose escalation study of LDK378 in pediatric patients with malignancies that have a genetic alteration in anaplastic lymphoma kinase…Ceritinib (LDK378)Novartis PharmaceuticalsClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.